|
Index of reports
> Cases with Cryptorchism ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viracept (Nelfinavir) where reactions include cryptorchism. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Viracept side effects in male
Reported by a health professional (non-physician/pharmacist) on 2011-10-12
Patient: male, weighing 3.4 kg (7.4 pounds)
Reactions: Gastroschisis, Abdominal Hernia, Maternal Drugs Affecting Foetus, Cardiac Murmur, Cryptorchism, Congenital Anomaly, Abdominal Distension, Exomphalos, Umbilical Hernia
Drug(s) suspected as cause:
Lamivudine
Dosage: 1200 mg (1200 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-06-01
Retrovir
Dosage: 600 mg (600 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Truvada
Dosage: 300 mg, transplacental
Indication: HIV Infection
Viracept
Dosage: 2500 mg (2500 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-06-01
Viread
Dosage: 300 mg (300 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-06-06
End date: 2004-09-10
Zidovudine
Dosage: 600 mg (600 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Indinivir Sulfate
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2004-06-01
End date: 2004-07-20
Kaletra
Dosage: 600 mg (600 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2001-06-01
Other drugs received by patient: Folic Acid
|
